{"id":8136,"date":"2026-07-08T07:13:20","date_gmt":"2026-07-08T07:13:20","guid":{"rendered":"https:\/\/chemsaxis.com\/?p=8136"},"modified":"2026-07-17T08:02:46","modified_gmt":"2026-07-17T08:02:46","slug":"%d1%80%d0%b8%d0%bb%d0%bc%d0%b0%d0%b7%d0%b0%d1%84%d0%be%d0%bd%d1%80%d0%b8%d1%82%d0%bc%d0%b8","status":"publish","type":"post","link":"https:\/\/chemsaxis.com\/ru\/rilmazafonerhythmy\/","title":{"rendered":"\u0420\u0438\u043b\u044c\u043c\u0430\u0437\u0430\u0444\u043e\u043d (\u0420\u0438\u0442\u043c\u0438)"},"content":{"rendered":"
\"Buy<\/a>
Rilmazafone(Rhythmy)<\/figcaption><\/figure>\n

Buy Rilmazafone online | Wholesale Rilmazafone<\/span><\/span><\/h1>\n

Buy Rilmazafone (Rhythmy) hydrochloride which is a benzodiazepine drug, easily soluble, affecting benzodiazepine receptors, has hypnotic effects. Rilmazafone was first developed in Japan as a tool that induces impairment of motor function and has hypnotic properties.<\/span><\/p>\n

Price:<\/p>\n

Rilmazafone 5 g 120 $\u00a0Add to cart<\/b><\/a><\/span><\/strong><\/p>\n

Rilmazafone 10 g 210$\u00a0Add to cart\u00a0<\/b><\/a><\/span><\/strong><\/p>\n

Rilmazafone<\/span>\u00a050 g 450 $\u00a0<\/span>Add to cart<\/span> <\/b><\/a><\/strong>Free shipping<\/span><\/span>!<\/strong><\/p>\n

Rilmazafone 100 g 750 $\u00a0Add to cart <\/b><\/a><\/span><\/strong>Free shipping<\/span><\/span>!<\/strong><\/p>\n

Rilmazafone 1 kg 4200 $\u00a0Add to cart <\/b><\/a><\/span><\/strong>Free shipping<\/span><\/span>!<\/strong><\/p>\n

You can buy Rilmazafone online in our store right now.<\/span><\/h2>\n
\n

Rilmazafone Application Scenarios<\/span><\/h2>\n<\/div>\n
\n
\n

Solvent-Free Aqueous Formulation<\/span><\/h3>\n

Due to its high polar solubility, rilmazafone is the ideal candidate for developing aqueous oral solutions and injectable formulations . Procuring this compound allows formulation chemists to bypass the use of propylene glycol or lipid emulsions, which are typically required for lipophilic benzodiazepines, thereby reducing injection-site pain and formulation instability.<\/span><\/p>\n

Aminopeptidase Activation Assays<\/span><\/h3>\n

Because the parent rilmazafone molecule lacks direct GABA_A receptor affinity, it serves as a precise tool for studying prodrug metabolism[1<\/a>]. Researchers can utilize it to isolate and quantify the specific enzymatic activity of intestinal aminopeptidases and the subsequent spontaneous ring-closure kinetics required to generate the active triazolobenzodiazepine metabolites.<\/span><\/p>\n

Behavioral Models with Motor Retention<\/span><\/h3>\n

In in vivo pharmacological models where post-sedation behavioral or cognitive testing is required, rilmazafone is preferred over triazolam or zolpidem [2<\/a>]. Its demonstrated ability to minimize residual ataxia in body sway tests ensures that subsequent motor coordination assays (e.g., rotarod or maze tests) are not confounded by prolonged psychomotor impairment.<\/span><\/p>\n

\n
\n
\n
\n

Rilmazafone: Water-Soluble Prodrug Precursor<\/span><\/h2>\n<\/div>\n
\n
\n

Buy Rilmazafone (CAS 99593-25-6) is an open-ring peptide aminobenzophenone that functions as a highly water-soluble prodrug to the triazolobenzodiazepine class . Unlike traditional lipophilic benzodiazepines, rilmazafone lacks a closed diazepine ring in its parent structure, rendering it inactive at \u03b3-aminobutyric acid type A (GABA_A) receptors prior to metabolic activation [1<\/a>]. Upon oral or systemic administration, it undergoes enzymatic cleavage by intestinal aminopeptidases followed by spontaneous cyclization to form active metabolites, primarily rilmazolam [1<\/a>]. This distinct structural profile provides significant procurement advantages for researchers requiring aqueous formulation compatibility, delayed in vivo activation, and a lack of direct in vitro receptor binding.<\/span><\/p>\n

\n
\n

Research Fit<\/span><\/h3>\n
\n
Workflow<\/span>Prodrug activation studies; intestinal aminopeptidase metabolism<\/span><\/span><\/div>\n
Selection Context<\/span>Water-soluble GABA-A research probe; distinct metabolite profile<\/span><\/span><\/div>\n
Use Context<\/span>Sleep-model research; comparative benzodiazepine pharmacology<\/span><\/span><\/div>\n<\/div>\n<\/section>\n<\/div>\n
\n

References<\/h3>\n